AREV Life Sciences Global Corp (AREVF) Stock
AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About AREV Life Sciences Global Corp
AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada. It is involved in the extraction of compounds for consumption and topical use; clinical nutrition business; and Medicine Merchant, a technology platform. The company's pipeline products include SUS-TAINN, a superior utility supplementation therapeutic agent for indicated nutritional needs; and RES-TORE, a product based on organic plant nutrition for patients with overt clinical need for rational enhanced caloric intake and micronutrient supplementation. It also develops edible oils, moringa, hops, cannabis sativa, pharma, sea cucumber, ginseng, and functional fungi ingredients; and anti-virals and phytomedicinalization. In addition, the company flash-freezes active ingredients, oils, and oleoresins for use as ingredients in food, nutraceuticals, and other consumer products. The company was formerly known as AREV NanoTec Brands Inc. and changed its name to AREV Life Sciences Global Corp. in August 2021. AREV Life Sciences Global Corp. is based in Coquitlam, Canada.
AREV Life Sciences Global Corp (AREVF) stock trades at $0.00 with a market capitalization of $15881. The stock is valued at a price-to-earnings (P/E) ratio of -1.87, price-to-book of -2.84, price-to-sales of 57.79. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.
On profitability, AREV Life Sciences Global Corp generates a return on equity (ROE) of 100.00% — well above the market average, a sign of a high-quality business, return on capital employed of 146.41%.
Official website: www.arevlifesciences.com